Volume | 35,742 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.656 | Mínimo Máximo |
|||||
Minimo del Dia | 2.4517 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Cocrystal Pharma Inc | COCP | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.59 | 2.4517 | 2.656 | 2.53 | 2.5801 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
264 | 35,742 | US$ 2.55 | US$ 91,040 | - | 1.325 - 3.285 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:00 | 25 | US$ 2.53 | USD |
Información Financiera Cocrystal Pharma Inc COCP
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
25.74M | 10.17M | - | 2.6M | -17.98M | -1.77 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Cocrystal Pharma Inc COCP
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
13/5/2024 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
13/5/2024 | 07:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports First Quarter 2024 Financial.. |
07/5/2024 | 15:30 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
01/5/2024 | 07:00 | GlobeNewswire Inc. | Enrollment Completed in Phase 2a Study with Cocrystal.. |
28/3/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Reports 2023 Financial Results and Provides.. |
19/3/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Receives Pre-IND Responses from the FDA on.. |
01/3/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
08/1/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
04/1/2024 | 07:00 | GlobeNewswire Inc. | Cocrystal Pharma Provides an Update on the Clinical.. |
02/1/2024 | 08:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
Histórico de Datos COCP
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.32 | 2.74 | 2.175 | 2.48 | 44,290 | 0.21 | 9.05% |
1 Month | 1.72 | 2.74 | 1.70 | 2.21 | 47,756 | 0.81 | 47.09% |
3 Months | 1.50 | 2.74 | 1.35 | 1.93 | 27,192 | 1.03 | 68.67% |
6 Months | 1.80 | 2.74 | 1.325 | 1.82 | 19,636 | 0.73 | 40.56% |
1 Year | 2.47 | 3.285 | 1.325 | 2.13 | 23,323 | 0.06 | 2.43% |
3 Years | 14.52 | 17.88 | 1.325 | 12.39 | 594,318 | -11.99 | -82.58% |
5 Years | 26.52 | 49.20 | 1.325 | 18.85 | 2,049,898 | -23.99 | -90.46% |